Mirabaud & Cie Sa Bio N Tech Se Transaction History
Mirabaud & Cie Sa
- $312 Billion
- Q4 2024
A detailed history of Mirabaud & Cie Sa transactions in Bio N Tech Se stock. As of the latest transaction made, Mirabaud & Cie Sa holds 6,000 shares of BNTX stock, worth $606,600. This represents 0.22% of its overall portfolio holdings.
Number of Shares
6,000Holding current value
$606,600% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.5MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$831 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$434 Million0.39% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$431 Million1.71% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$192 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$183 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...